ACM
CYCN icon

ADAR1 Capital Management’s Cyclerion Therapeutics CYCN Stock Holding History

ADAR1 Capital Management’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
+298,757
New +$969K 0.05% 167

Other funds holding CYCN

KCM
Kalehua Capital Management Dallas, Texas $140M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ADAR1 Capital Management's CYCN Position: Q2 2026 in Review

ADAR1 Capital Management opened a new position in Cyclerion Therapeutics (CYCN) in Q2 2026: 298,757 shares worth $1.01M. The stake represents 0.05% of the portfolio and ranks #167 among its holdings.

21 funds tracked by Wall St. Rank hold CYCN as of Q2 2026.

  • ADAR1 Capital Management held 298,757 shares of Cyclerion Therapeutics worth $1.01M as of Q2 2026.
  • Cyclerion Therapeutics was a new ADAR1 Capital Management position in Q2 2026.
  • Cyclerion Therapeutics made up 0.05% of ADAR1 Capital Management's portfolio in Q2 2026, its #167 holding.
  • 21 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.